Table 3 Prescription practices and expectation on prescription among healthcare providers (20 males and 34 females)
| Â | Male | Female | Total |
|---|---|---|---|
N (%) | N (%) | N (%) | |
Laboratory examination | |||
 Blood test for every case | 2 (10.0) | 1 (2.9) | 3 (5.6) |
 Blood testing for selected cases | 17 (85.0) | 30 (88.2) | 47 (87.0) |
 Based on symptoms | 20 (100.0) | 34 (100.0) | 54 (100.0) |
 Based on full examination | 16 (80.0) | 24 (70.6) | 40 (74.1) |
 In case of an enough time available | 15 (75.0) | 30 (88.2) | 45 (83.3) |
Reason for AB prescription | |||
 Base on observed symptoms | 20 (100.0) | 33 (97.1) | 53 (98.1) |
 Just for prevention | 2 (10.0) | 0 (0.0) | 2 (3.7) |
 Based on experiences | 5 (25.0) | 5 (14.7) | 10 (18.5) |
Expectation from prescribing practice | |||
 Being confident for AB prescription | 20 (100.0) | 30 (88.2) | 50 (92.6) |
 Have concerns about quality of AB prescribed | 17 (85.0) | 22 (64.7) | 39 (72.2) |
 Have concerns about compliance to the advice | 18 (90.0) | 25 (73.5) | 43 (79.6) |
 Have concerns about self-medication of AB | 18 (90.0) | 28 (82.4) | 46 (85.2) |
 Have concerns about AB resistant | 19 (95.0) | 30 (88.2) | 49 (90.7) |
 Have concerns about adverse effects and resistance | 20 (100.0) | 29 (85.3) | 49 (90.7) |